Abdominal Aortic Stent Grafts Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500
Buy Report Download FREE Resources

Published: September 17, 2024 Report Code: GDME1817EPD-ST

Select Item

Abdominal Aortic Stent Grafts Pipeline Market Report Overview

Abdominal aortic stent grafts are used to treat abdominal aortic aneurysms by reinforcing a part of the aorta using a minimally invasive procedure. The abdominal aortic stent grafts pipeline market research report comprehensive information about the key pipeline products with a comparative analysis of the products at various stages of development. The report also includes information about the abdominal aortic stent grafts clinical trials which are in progress.

Key Territories ·       The US

·       Europe

·       Japan

·       China

·       Colombia
Key Regulatory Paths ·       PMA

·       CE

·       Shonin

·       NMPA

·       TGA
Leading Companies ·       Affluent Medical SASU

·       Angiolutions UG

·       BiFlow Medical Ltd

·       Cook Medical Inc

·       Cytograft Tissue Engineering Inc (Inactive)
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Abdominal Aortic Stent Grafts Pipeline Market Segmentation by Territories

The key territories in the abdominal aortic stent grafts pipeline market are the US, Europe, Japan, China, and Colombia among others. As of September 2024, the US accounts for the highest number of pipeline products.

Abdominal Aortic Stent Grafts Pipeline Market Analysis by Territories, 2024 (%)

Abdominal Aortic Stent Grafts Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Abdominal Aortic Stent Grafts Pipeline Market

Download a Free Report Sample

Abdominal Aortic Stent Grafts Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the abdominal aortic stent grafts pipeline products market are PMA, CE, Shonin, NMPA, and TGA among others. As of September 2024, PMA is the most followed pathway for pipeline products in the abdominal aortic stent grafts market.

Abdominal Aortic Stent Grafts Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Abdominal Aortic Stent Grafts Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Abdominal Aortic Stent Grafts Pipeline Market

Download a Free Report Sample

Abdominal Aortic Stent Grafts Pipeline Market – Competitive Landscape

A few of the leading companies associated with the abdominal aortic stent grafts pipeline market are:

  • Affluent Medical SASU
  • Angiolutions UG
  • BiFlow Medical Ltd
  • Cook Medical Inc
  • Cytograft Tissue Engineering Inc (Inactive)

Affluent Medical SASU: Affluent Medical SASU is a France-based company that manufactures surgical implants. It designs minimally invasive prostheses aimed at mimicking human anatomy and restoring native physiology for critical functions within the cardiovascular and urological system.

BiFlow Medical Ltd: Headquartered in Caesarea, Israel, BiFlow Medical Ltd (BiFlow) is a medical device company. BiFlow develops a unique side-branch stent that is used for percutaneous procedures in endovascular stent grafting.

Abdominal Aortic Stent Grafts Pipeline Market Analysis by Companies, 2024

Abdominal Aortic Stent Grafts Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Abdominal Aortic Stent Grafts Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Abdominal Aortic Stent Grafts Pipeline Market Territories Outlook (2024)

  • The US
  • Europe
  • Japan
  • China
  • Colombia

Abdominal Aortic Stent Grafts Pipeline Market Regulatory Paths Outlook (2024)

  • PMA
  • CE
  • Shonin
  • NMPA
  • TGA

Scope

This report provides:

  • An extensive coverage of the abdominal aortic stent grafts under development.

  • A detailed list of major pipeline products which includes product description, licensing and collaboration details, and other developmental activities.

  • Reviews of major players involved in the development of abdominal aortic stent grafts and lists of all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Key clinical trial data of ongoing clinical trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of abdominal aortic stent grafts under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Affluent Medical SASU
Angiolutions UG
BiFlow Medical Ltd
Cook Medical Inc
Cytograft Tissue Engineering Inc (Inactive)
Endologix LLC
Endoluminal Sciences Pty Ltd
Hadassah Medical Center
Johns Hopkins University
Kawasumi Laboratories Inc
Lombard Medical Technologies Inc.
Lombard Medical Technologies Ltd (Inactive)
Medtronic Plc
MicroPort Scientific Corp
St. Jude Medical LLC
Terumo Aortic
University of Colorado Denver
University of Limerick
Venus Medtech Hangzhou Inc

Table of Contents

  • 1. Table of Contents

    • 1.1. List of Tables

    • 1.2. List of Figures

  • 2. Introduction

    • 2.1. Abdominal Aortic Stent Grafts Overview

  • 3. Products under Development

    • 3.1. Abdominal Aortic Stent Grafts – Pipeline Products by Stage of Development

    • 3.2. Abdominal Aortic Stent Grafts – Pipeline Products by Segment

    • 3.3. Abdominal Aortic Stent Grafts – Pipeline Products by Territory

    • 3.4. Abdominal Aortic Stent Grafts – Pipeline Products by Regulatory Path

    • 3.5. Abdominal Aortic Stent Grafts – Pipeline Products by Estimated Approval Date

    • 3.6. Abdominal Aortic Stent Grafts – Ongoing Clinical Trials

  • 4. Abdominal Aortic Stent Grafts – Pipeline Products under Development by Companies

    • 4.1. Abdominal Aortic Stent Grafts Companies – Pipeline Products by Stage of Development

    • 4.2. Abdominal Aortic Stent Grafts – Pipeline Products by Stage of Development

  • 5. Abdominal Aortic Stent Grafts Companies and Product Overview

    • 5.1. Affluent Medical SASU Company Overview

      • 5.1.1. Affluent Medical SASU Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2. Angiolutions UG Company Overview

      • 5.2.1. Angiolutions UG Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3. BiFlow Medical Ltd Company Overview

      • 5.3.1. BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4. Cook Medical Inc Company Overview

      • 5.4.1. Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5. Cytograft Tissue Engineering Inc (Inactive) Company Overview

      • 5.5.1. Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6. Endologix LLC Company Overview

      • 5.6.1. Endologix LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7. Endoluminal Sciences Pty Ltd Company Overview

      • 5.7.1. Endoluminal Sciences Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8. Hadassah Medical Center Company Overview

      • 5.8.1. Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9. Johns Hopkins University Company Overview

      • 5.9.1. Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10. Kawasumi Laboratories Inc Company Overview

      • 5.10.1. Kawasumi Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11. Lombard Medical Technologies Inc. Company Overview

      • 5.11.1. Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12. Lombard Medical Technologies Ltd (Inactive) Company Overview

      • 5.12.1. Lombard Medical Technologies Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13. Medtronic Plc Company Overview

      • 5.13.1. Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14. MicroPort Scientific Corp Company Overview

      • 5.14.1. MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15. St. Jude Medical LLC Company Overview

      • 5.15.1. St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16. Terumo Aortic Company Overview

      • 5.16.1. Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17. University of Colorado Denver Company Overview

      • 5.17.1. University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview

    • 5.18. University of Limerick Company Overview

      • 5.18.1. University of Limerick Pipeline Products & Ongoing Clinical Trials Overview

    • 5.19. Venus Medtech Hangzhou Inc Company Overview

      • 5.19.1. Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview

  • 6. Abdominal Aortic Stent Grafts- Recent Developments

    • 6.1. Aug 30, 2024: MicroPort Scientific Reports Earnings Results for the Half Year Ended June 30, 2024

    • 6.2. Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

    • 6.3. Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

    • 6.4. Aug 08, 2024: Terumo India Launches Treo Abdominal Stent-graft System

    • 6.5. Jun 13, 2024: Medtronic Confirms Global Layoffs

    • 6.6. Mar 14, 2024: Endologix to Present at Upcoming LSI US ’24 Emerging Medtech Summit

    • 6.7. Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference

    • 6.8. Jan 31, 2024: First Patient Treated in the Clinical Study of the ZENITH FENESTRATED+ Endovascular Graft

    • 6.9. Sep 21, 2023: Microport Endovastec Completes the First Clinical Implantation of Minos Stent Graft System in Azerbaijan

  • 7. Appendix

    • 7.1. Methodology

    • 7.2. About GlobalData

    • 7.3. Contact Us

    • 7.4. Disclaimer

Table

Abdominal Aortic Stent Grafts – Pipeline Products by Stage of Development 9

Abdominal Aortic Stent Grafts – Pipeline Products by Segment 10

Abdominal Aortic Stent Grafts – Pipeline Products by Territory 11

Abdominal Aortic Stent Grafts – Pipeline Products by Regulatory Path 12

Abdominal Aortic Stent Grafts – Pipeline Products by Estimated Approval Date 13

Abdominal Aortic Stent Grafts – Ongoing Clinical Trials 14

Abdominal Aortic Stent Grafts Companies – Pipeline Products by Stage of Development 15

Abdominal Aortic Stent Grafts – Pipeline Products by Stage of Development 16

Affluent Medical SASU Pipeline Products & Ongoing Clinical Trials Overview 17

Kardiozis – Product Status 17

Kardiozis – Product Description 17

Angiolutions UG Pipeline Products & Ongoing Clinical Trials Overview 18

Vascular Graft (A3-Shield) – Product Status 18

Vascular Graft (A3-Shield) – Product Description 18

BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 19

Nitinol Side Branch Stent – Product Status 19

Nitinol Side Branch Stent – Product Description 19

Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 20

Zenith Fenestrated+ Endovascular Graft – Product Status 20

Zenith Fenestrated+ Endovascular Graft – Product Description 20

Zenith P-Branch – Product Status 21

Zenith P-Branch – Product Description 21

Cook Medical Inc – Ongoing Clinical Trials Overview 22

Zenith P-Branch – Evaluation of Visceral Function Following Endovascular Aortic Aneurysm Repair Using Branched Stent- Grafts 23

Zenith Fenestrated+ Endovascular Graft – Safety and Effectiveness of Surgeon-Modified Fenestrated and Branched Endografts in Treating Subjects With Complex Aortic Aneurysms 24

Zenith Fenestrated+ Endovascular Graft – Zenith Fenestrated+ Endovascular Graft Clinical Study 24

Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 25

LifeJacket AAA Stent Graft – Product Status 25

LifeJacket AAA Stent Graft – Product Description 25

Endologix LLC Pipeline Products & Ongoing Clinical Trials Overview 26

AFX2 Bifurcated Endograft System – Product Status 26

AFX2 Bifurcated Endograft System – Product Description 27

AFX3 – Product Status 27

AFX3 – Product Description 27

AFX4 – Product Status 28

AFX4 – Product Description 28

Nellix 3.5 – Product Status 28

Nellix 3.5 – Product Description 29

Nellix CHEVAS – Product Status 29

Nellix CHEVAS – Product Description 29

Nellix With Snorkels – Product Status 30

Nellix With Snorkels – Product Description 30

Next Gen EVAS – Product Status 30

Next Gen EVAS – Product Description 30

Paravisceral System – Product Status 31

Paravisceral System – Product Description 31

Ventana 2 – Product Status 31

Ventana 2 – Product Description 32

Xpand BX Covered Stent – Product Status 32

Xpand BX Covered Stent – Product Description 32

Endologix LLC – Ongoing Clinical Trials Overview 33

Nellix CHEVAS – Prospective, Multicenter, Non-randomized Study with Consecutive, Eligible Subject Enrollment at Each Site, for the Evaluation of the ChEVAS System for Endovascular Repair of Paravisceral, Juxtarenal, and Pararenal Abdominal Aortic Aneurysms 34

Endoluminal Sciences Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 35

Stent-Graft With Adhesive Delivery Platform – Product Status 35

Stent-Graft With Adhesive Delivery Platform – Product Description 35

Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 36

In Situ Weldable Hybrid Stent – Product Status 36

In Situ Weldable Hybrid Stent – Product Description 36

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 37

Scaly Aortic Stent Graft – Product Status 37

Scaly Aortic Stent Graft – Product Description 37

Kawasumi Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 38

Abdominal Aortic Aneurysm Stent Graft – Product Status 38

Abdominal Aortic Aneurysm Stent Graft – Product Description 38

Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 39

FEVAR – Product Status 39

FEVAR – Product Description 39

Lombard Medical Technologies Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 40

Low Profile Stent Graft – Product Status 40

Low Profile Stent Graft – Product Description 40

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 41

Endurant Evo AAA Stent Graft System – Product Status 41

Endurant Evo AAA Stent Graft System – Product Description 41

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 42

Aegis II Abdominal Aortic Stent Graft System – Product Status 42

Aegis II Abdominal Aortic Stent Graft System – Product Description 42

St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 43

Amplatzer AAA Vascular Graft – Product Status 43

Amplatzer AAA Vascular Graft – Product Description 43

Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview 44

BoulEVARd Stent – Product Status 44

BoulEVARd Stent – Product Description 44

University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview 45

Shape Memory Polymer Arterial Stent – Product Status 45

Shape Memory Polymer Arterial Stent – Product Description 45

University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 46

Cardiovascular Graft – Product Status 46

Cardiovascular Graft – Product Description 46

Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview 47

Tumbao EndoVascular Aortic Repair System – Product Status 47

Tumbao EndoVascular Aortic Repair System – Product Description 47

Glossary 53

Figures

Abdominal Aortic Stent Grafts – Pipeline Products by Stage of Development 9

Abdominal Aortic Stent Grafts – Pipeline Products by Segment 10

Abdominal Aortic Stent Grafts – Pipeline Products by Territory 11

Abdominal Aortic Stent Grafts – Pipeline Products by Regulatory Path 12

Abdominal Aortic Stent Grafts – Pipeline Products by Estimated Approval Date 13

Abdominal Aortic Stent Grafts – Ongoing Clinical Trials 14

Frequently asked questions

Abdominal Aortic Stent Grafts Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

Most Popular
$5,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Abdominal Aortic Stent Grafts Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Abdominal Aortic Stent Grafts reports
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Abdominal Aortic Stent Grafts Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Abdominal Aortic Stent Grafts Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more